Department of Pediatric Surgery, Yeouido St. Mary's Hospital, The Catholic University of Korea, 62 Youido-dong, Youngdeungpo-gu, Seoul 150-713, South Korea.
J Pediatr Surg. 2012 Sep;47(9):E37-40. doi: 10.1016/j.jpedsurg.2012.06.022.
Thyroglossal duct cyst (TGDC) is one of most common congenital diseases of the midline of the neck. Most TGDC cases require treatment in the cases of cosmetic problems or recurrent infection, and a Sistrunk operation is considered to be the standard treatment. However, less invasive treatments are sometimes used, and sclerotherapy with OK-432 or ethanol is one such method. However, the validity or use of sclerotherapy as a TGDC treatment is controversial because cases of TGDC that have been successfully treated with sclerotherapy are rare, and the follow-up period is short, and there are no statistical reports about the reoccurrence of symptoms after sclerotherapy. In this report, we review 2 recurrent TGDC cases after sclerotherapy with OK-432 and ethanol and discuss the efficacy and limitations of sclerotherapy.
甲状舌管囊肿（TGDC）是颈部中线最常见的先天性疾病之一。大多数 TGDC 病例需要在出现美容问题或反复感染的情况下进行治疗，Sistrunk 手术被认为是标准治疗方法。然而，有时也会使用侵袭性较小的治疗方法，OK-432 或乙醇硬化疗法就是其中之一。然而，作为 TGDC 治疗方法的硬化疗法的有效性或用途存在争议，因为成功接受硬化疗法治疗的 TGDC 病例很少，随访时间短，并且没有关于硬化疗法后症状复发的统计报告。在本报告中，我们回顾了 OK-432 和乙醇硬化疗法治疗后复发的 2 例 TGDC 病例，并讨论了硬化疗法的疗效和局限性。
